Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2001 5
2002 14
2003 4
2004 11
2005 16
2006 19
2007 21
2008 14
2009 12
2010 9
2011 23
2012 12
2013 15
2014 7
2015 9
2016 6
2017 12
2018 11
2019 13
2020 17
2021 22
2022 16
2023 27
2024 32

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, Hardt-Lindberg S, Hovingh GK, Kahn SE, Kushner RF, Lingvay I, Oral TK, Michelsen MM, Plutzky J, Tornøe CW, Ryan DH; SELECT Trial Investigators. Lincoff AM, et al. N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11. N Engl J Med. 2023. PMID: 37952131 Clinical Trial.
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.
Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM; ODYSSEY OUTCOMES Committees and Investigators. Schwartz GG, et al. N Engl J Med. 2018 Nov 29;379(22):2097-2107. doi: 10.1056/NEJMoa1801174. Epub 2018 Nov 7. N Engl J Med. 2018. PMID: 30403574 Free article. Clinical Trial.
Author's Reply.
Barkas F, Liberopoulos E, Rizos EC. Barkas F, et al. Among authors: liberopoulos e. J Cardiol. 2020 Feb;75(2):217. doi: 10.1016/j.jjcc.2019.08.009. Epub 2019 Sep 20. J Cardiol. 2020. PMID: 31543379 Free article. No abstract available.
Hypocholesterolemia.
Moutzouri E, Elisaf M, Liberopoulos EN. Moutzouri E, et al. Among authors: liberopoulos en. Curr Vasc Pharmacol. 2011 Mar;9(2):200-12. doi: 10.2174/157016111794519354. Curr Vasc Pharmacol. 2011. PMID: 20626336
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Among authors: liberopoulos e. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
Oxidized phospholipids and lipoprotein(a): An update.
Koutsogianni AD, Liberopoulos E, Tellis K, Tselepis AD. Koutsogianni AD, et al. Among authors: liberopoulos e. Eur J Clin Invest. 2022 Apr;52(4):e13710. doi: 10.1111/eci.13710. Epub 2021 Nov 27. Eur J Clin Invest. 2022. PMID: 34837383 Review.
304 results